Tackling COVID-19

To support the drug discovery community in the challenge to identify efficacious COVID-19 drugs, we have developed specific assays to block SARS-CoV-2 virus entry and replication, including:

•Biophysical binding assays to block S protein and ACE2 interaction.

•Enzymatic inhibition assays for Furin,  PLpro, Cathepsin L proteases and, coming soon, Mpro and TMPRSS2.

Contact us for fast support of your drug discovery project with the highest quality standards.

 

Latest News

Newsletter

Stay informed/Get special offers